Median Cost Per Patient for Orphan Drugs is 5.5 Times Higher Than Non-Orphan Drugs
March 01, 2017
Changing Faces: The Interim Manager
A look at how pharma and biotech interim management has evolved in the last 20 years.
Pharmaceutical Executive, March 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2017 issue in an interactive PDF format.
Uphill Work to Realize Dreams of Rare Disease Treatment
February 28, 2017
EuropaBio Calls for Strengthening of SME Biotech Sector
Big Data, Big Opportunities in Life Sciences
Rheumatoid Arthritis Market to Hit $28.5 Billion by 2025
February 23, 2017
Europe "Must Adopt the CETA Manufacturing Waiver "
February 22, 2017
EFPIA Confirms New Director General Appointment
FDA Promotes Diversity in Clinical Trials
February 17, 2017
The Broad Institute Triumphs in CRISPR Patent Battle
Manufacturers "Must Address Low Medication Compliance Among Lupus Patients"
Not Your Typical Pharma Dateline
Recent events you may have missed on the global pharma scene.
Pharmaceutical Executive, February 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2017 issue in an interactive PDF format.
London School of Economics Establishes Market Access Academy
January 24, 2017
A High-Touch Approach to Product Access
Transformation Initiatives Underway for Regulatory Information Management
Top Tweets from J.P. Morgan 2017
Pharm Exec is back at the 2017 J.P. Morgan Healthcare Conference in San Francisco, CA.
Win Your Brand with Action
The seven ways for pharmas to ensure successful execution of action steps following brand "war games."
Pharmaceutical Executive, January 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive January 2017 issue in an interactive PDF format.
Electrical Pulses Spark New Ways to Treat Diseases
Anthony Arnold offers an overview and update of bioelectronic medicine.
Will NICE ‘Go Commercial’?
That may be one option as the UK agency, like the NIH it supports, looks at how to generate big savings.
Pharmaceutical Executive, December 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive December 2016 issue in an interactive PDF format.
Andrew Witty: Volume is Not a Dirty Word
“Volume is not a dirty word” was outgoing GSK head Sir Andrew Witty’s key message at last week’s FT Global Pharmaceutical Conference in London.
The Cancer Care Conundrum in Europe
Cancer treatment is an increasing dilemma for EU health services as they try to balance patient care against budgetary constraints.
Has Gastein Peaked?
This year’s 19th annual European Health Forum Gastein (Austria) once again attempted to establish unity in the face of EU woes. But are the Gastein region’s “healing powers” on the wane?
Pharmaceutical Executive, November 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive November 2016 issue in an interactive PDF format.
PE Media Planner 2017
New Challenge to IP Innovation
Survey on the rising use of Inter Partes Reviews to challenge patents reveals key considerations for originator companies.
Major Changes Ahead for Drug User Fees
PDUFA VI to enhance FDA staffing, revise fees and expand evidence for drug development.
